株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の病院・民間検査所・ポイントオブケア(POC)向け血液凝固検査市場

US Coagulation Testing Market: Hospitals, Commercial Laboratories, POC Locations

発行 Venture Planning Group 商品コード 305192
出版日 ページ情報 英文 455 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

Local License: 同一事業所内

Back to Top
米国の病院・民間検査所・ポイントオブケア(POC)向け血液凝固検査市場 US Coagulation Testing Market: Hospitals, Commercial Laboratories, POC Locations
出版日: ページ情報: 英文 455 Pages
概要

当レポートでは、米国の各種医療機関(病院・民間検査所・ポイントオブケア(POC)など)向けの血液凝固検査関連の市場について分析し、今後5年間の市場動向の見通し(検査装置・試薬の売上高や検査件数など)を初め、部門別の詳細動向、関連技術の最新の開発状況、規制環境、競争構造、今後の市場の方向性、主要企業のプロファイルなどを調査しております。

第1章 イントロダクション

第2章 世界市場と技術概要

  • 主な血液凝固検査(ルーチン検査・特別検査)
    • イントロダクション
    • APTT(活性化部分トロンボプラスチン時間)
    • α2抗プラズミン物質
    • 抗トロンビンIII
    • 出血時間
    • D-ダイマー
    • エタノール凝固テスト
    • ユーグロブリン溶解
    • 因子測定(全12種類)
    • フィブリン分解物
    • フィブリノゲン(線維素原)
    • ヘパリン
    • ヒルジン
    • 凝血能亢進および血栓症
    • リポたんぱく質A
    • プラスミン
    • プラスミノゲン
    • プラスミノゲン活性化因子阻害因子(PAI)
    • 血小板機能検査
    • 血小板凝集
    • プロテインC&S
    • プロトロンビンフラグメント1.2
    • プロトロンビン時間(PT)
    • レプチラーセ時間
    • トロンビン時間
    • t-PA(組織型プラスミノゲン活性化因子)
    • フォン・ヴィレブランド因子
  • 各種装置のレビュー
  • 主要な体外診断技術と潜在的な用途
    • 発色基質
    • モノクローナル抗体とポリクローナル抗体
    • 免疫学的検定
    • 分子診断
    • マイクロコンピュータ
    • オートメーション
    • ロボット工学
    • 人工知能
    • ドライケミストリー
    • バイオセンサー

第3章 米国市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 分散型検査製品の合理的根拠
    • 概要
    • 規制動向
    • 経済動向
    • 人口構造の動向
    • 技術動向
    • 社会動向
    • 医療水準
    • 保身的医療
    • 品質管理の問題
  • 市場規模・成長率、主な検査装置・試薬サプライヤーの売上高と市場シェア

第4章 主な製品開発機会

第5章 分散検査製品の設計基準

第6章 代替的な市場参入戦略

  • 内部開発
  • 協働事業協定
  • 大学との契約
  • 分散検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

第7章 潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 最先端技術とその限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

第8章 競争戦略

  • Abbott
  • ADI/American Diagnostic
  • Axis-Shield
  • Alere/Biosite/Inverness
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data Corporation
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago/Trinity Biotech
  • Grifols
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Roche
  • Siemens
  • Sienco
  • シスメックス
  • Thermo Fischer
  • ZyCare/Alere

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCO20008

Summary

This comprehensive report contains 455 pages, 60 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years.

The report explores business and technological trends in the US coagulation testing market; provides leading supplier market shares estimates, as well as test volume forecasts for over 40 procedures performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care center, surgery centers, nursing homes, and birth centers; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Strategic Recommendations

- Product development and business expansion opportunities with significant market appeal.

- “Ideal” product models with tentative prices and operating characteristics.

- Alternative market penetration strategies for instrument and reagent suppliers.

- Potential market entry barriers and risks.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Sales and Market Share Analysis

- Sales and market shares of major instrument and reagent suppliers.

Market Segmentation Analysis

- Comprehensive market segmentation analysis, including:

Centralized Testing

- Hospitals Commercial/Private Laboratories

POC/Decentralized Testing

- Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers

- Test volume forecasts for over 40 major procedures by market segment.

Current and Emerging Products

- Review of established and emerging procedures.

- Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies and their potential market applications.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

Competitive Strategies

- Extensive strategic profiles of major suppliers and emerging market entrants.

- The companies analyzed in the report include:

-  Abbott   ADI/American Diagnostica   Alere/Biosite/Inverness   Axis-Shield   Beckman Coulter/Danaher   Becton Dickinson   Bio/Data Corporation   Chrono-Log   Corgenix Medical/ Orgentec   Diagnostica Stago/Trinity Biotech   Grifols   Helena Laboratories   Hyphen BioMed   Instrumentation Laboratory   ITC/Nexus Dx   Roche   Siemens   Sienco   Sysmex   Thermo Fisher   ZyCare/Alere

Contains 455 pages and 60 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

  • A. Major Routine and Special Coagulation Tests
    • 1. Introduction
    • 2. Activated Partial Thromboplastin Time (APTT)
    • 3. Alpha-2 Antiplasmin
    • 4. Antithrombin III
    • 5. Bleeding Time
    • 6. D-Dimer
    • 7. Ethanol Flocculation Test
    • 8. Euglobulin Lysis
    • 9. Factor Assays
      • a. Introduction
      • b. Factor II
      • c. Factor V/Factor V Leiden
      • d. Factor VII
      • e. Factor VIII
      • f. Factor IX
      • g. Factor IXa
      • h. Factor X (Stuart Factor)
      • i. Factor Xa
      • j. Factor XI
      • k. Factor XII
      • l. Factor XIII
    • 10. Fibrin Degradation Products
    • 11. Fibrinogen
    • 12. Heparin
    • 13. Hirudin
    • 14. Hypercoagulability and Thrombosis
    • 15. Lipoprotein a
    • 16. Plasmin
    • 17. Plasminogen
    • 18. Plasminogen Activator Inhibitor (PAI)
    • 19. Platelet Function Tests
    • 20. Platelet Aggregation
    • 21. Proteins C and S
    • 22. Prothrombin Fragment 1.2
    • 23. Prothrombin Time (PT)
    • 24. Reptilase Time
    • 25. Thrombin Time
    • 26. Tissue-Type Plasminogen Activator (t-PA)
    • 27. Von Willebrand's Factor
  • B. Instrumentation Review
  • C. Major in Vitro Diagnostic Technologies and Their Potential Applications
    • 1. Chromogenic Substrates
    • 2. Monoclonal and Polyclonal Antibodies
    • 3. Immunoassays
    • 4. Molecular Diagnostics
    • 5. Microcomputers
    • 6. Automation
    • 7. Robotics
    • 8. Artificial Intelligence
    • 9. Dry Chemistry
    • 10. Biosensors

III. U.S.A.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Rationale for Testing Decentralization
    • 1. Overview
    • 2. Regulatory Trends
    • 3. Economic Trends
    • 4. Demographic Trends
    • 5. Technological Trends
    • 6. Social Trends
    • 7. Quality of Care
    • 8. Defensive Medicine
    • 9. Quality Control Issues
  • E. Market Size, Growth and Major Instrument and Reagent Suppliers' Sales and Market Shares

IV. Major Product Development Opportunities

V. Design Criteria For Decentralized Testing Products

VI. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation

VII. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VIII. Competitive Strategies

  • Abbott
  • ADI/American Diagnostic
  • Axis-Shield
  • Alere/Biosite/Inverness
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data Corporation
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago/Trinity Biotech
  • Grifols
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fischer
  • ZyCare/Alere

List of Tables

  • Major Companies Developing or Marketing Activated Clotting Time Tests
  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
  • Major Companies Developing or Marketing Antithrombin III Tests
  • Major Companies Developing or Marketing Bleeding Time Tests
  • Major Companies Developing or Marketing D-dimer Tests
  • Major Companies Developing or Marketing Factor Assays
  • Major Companies Developing or Marketing Fibrin Degradation Product Tests
  • Major Companies Developing or Marketing Fibrinogen Tests
  • Major Companies Developing or Marketing Heparin Tests
  • Major Companies Developing or Marketing Plasmin Tests
  • Major Companies Developing or Marketing Plasminogen Tests
  • Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
  • Major Companies Developing or Marketing Platelet Aggregation Tests
  • Major Companies Developing or Marketing Protein C Tests
  • Major Companies Developing or Marketing Protein S Tests
  • Major Companies Developing or Marketing PT Tests
  • Major Companies Developing or Marketing Thrombin Time Tests
  • Major Companies Developing or Marketing TPA Tests
  • Major Companies Developing or Marketing Von Willebrand's Factor Tests
  • Executive Summary Table: U.S.A., Total Coagulation Diagnostics Market By Market Segment and Product Category
  • U.S.A., Laboratories Performing Coagulation Tests By Market Segment
  • U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
  • U.S.A., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
  • U.S.A., Hospital Laboratories Average Daily Test Volume
  • U.S.A., Commercial/Private Laboratories Average Daily Test Volume
  • U.S.A., Physician Offices/Group Practices Average Daily Test Volume
  • U.S.A., Total Coagulation Test Volume By Market Segment
  • U.S.A., All Market Segments Coagulation Test Volume
  • U.S.A., Hospital Laboratories Coagulation Test Volume
  • U.S.A., Commercial/Private Laboratories Coagulation Test Volume
  • U.S.A., Physician Offices/Group Practices Coagulation Test Volume
  • U.S.A., Coagulation Reagent Market By Market Segment
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Coagulation Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Hospital Operating and Recovery Suites Coagulation Test Volume Forecast
  • U.S.A., Hospital Operating and Recovery Suites Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Hospital ICUs/CCUs Coagulation Test Volume Forecast
  • U.S.A., Hospital ICUs/CCUs Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Cancer Clinics Major Coagulation Test Volume Forecast
  • U.S.A., Cancer Clinics Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care CentersMost Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Coagulation Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers Coagulation Test Volume Forecast
  • U.S.A., Surgery Centers Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
  • U.S.A., Nursing Homes Coagulation Test Volume Forecast
  • U.S.A., Nursing Homes Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers Coagulation Test Volume Forecast
  • U.S.A., Birth Centers Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares
  • U.S.A., Coagulation Instrument Market By Market Segment
  • U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
  • U.S.A., Total Coagulation Diagnostics Market By Product Category
  • U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares
Back to Top